{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T09:46:18Z","timestamp":1783158378480,"version":"3.54.6"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81660309"],"award-info":[{"award-number":["No. 81660309"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guizhou Medical University PhD Startup Fund Project","award":["YJ2016-10"],"award-info":[{"award-number":["YJ2016-10"]}]},{"name":"Guizhou Province Engineering Technology Research Center Project","award":["Qian High-Tech of Development and Reform Commission NO. [2016]1345"],"award-info":[{"award-number":["Qian High-Tech of Development and Reform Commission NO. [2016]1345"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Coronary heart disease is related to sudden death caused by multi-factors and a major threat to human health.This study explores the role of OX40L and ICAM-1 in the stability of coronary plaques and their relationship with sudden coronary death.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 118 human coronary arteries with different degrees of atherosclerosis and\/or sudden coronary death comprised the experimental group and 28 healthy subjects constituted the control group were isolated from patients. The experimental group was subdivided based on whether the cause of death was sudden coronary death and whether it was accompanied by thrombosis, plaque rupture, plaque outflow and other secondary changes: group I: patients with coronary atherosclerosis but not sudden coronary death, group II: sudden coronary death without any of the secondary changes mentioned above, group III: sudden coronary death with coronary artery atherosclerotic lesions accompanied by either of the above secondary changes. The histological structure of the coronary artery was observed under a light microscope after routine HE staining, and the related indexes of atherosclerotic plaque lesions were assessed by image analysis software. The expressions of OX40L and ICAM-1 were detected by real-time quantitative PCR (RT-PCR), immunohistochemistry (IHC) and Western blotting, and the correlations between the expressions and the stability of coronary atherosclerotic plaque and sudden coronary death were analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>(1) The expression of OX40L protein in the control group and the three experimental groups showed an increasing trend, and the difference between groups was statistically significant (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). (2) The expression of the ICAM-1 protein in the control group and the three experimental groups showed a statistically significant (<jats:italic>P\u2009&lt;<\/jats:italic>\u00a00.05) increasing trend. (3) The expression of OX40L and ICAM-1 mRNAs increased in the control and the three experimental groups and the difference was statistically significant (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The expression of OX40L and ICAM-1 proteins and mRNAs is positively correlated with the stability of coronary atherosclerotic plaque and sudden coronary death.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12872-019-1251-8","type":"journal-article","created":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T12:02:35Z","timestamp":1575028955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The role of OX40L and ICAM-1 in the stability of coronary atherosclerotic plaques and their relationship with sudden coronary death"],"prefix":"10.1186","volume":"19","author":[{"given":"Yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiyun","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9382-9496","authenticated-orcid":false,"given":"Jiawen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changwu","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,29]]},"reference":[{"key":"1251_CR1","doi-asserted-by":"crossref","unstructured":"Marsche G. Lp-PLA 2, Plaque Inflammation and Lesion Development Vary Fundamentally Between Different Vascular Sites. J Am Heart Assoc. 2015;4(2):e001800.","DOI":"10.1161\/JAHA.115.001800"},{"issue":"9","key":"1251_CR2","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.4049\/jimmunol.1200708","volume":"191","author":"AC Foks","year":"2013","unstructured":"Foks AC, van Puijvelde GH, Bot I, et al. Interruption of the OX40-OX40 ligand pathway in LDL receptor-deficient mice causes regression of atherosclerosis. J Immunol. 2013;191(9):4573\u201380.","journal-title":"J Immunol"},{"issue":"3","key":"1251_CR3","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/cvr\/cvq211","volume":"88","author":"M Nakano","year":"2010","unstructured":"Nakano M, Fukumoto Y, Satoh K, et al. OX40 ligand plays an important role in the development of atherosclerosis through vasa vasorum neovascularization. Cardiovasc Res. 2010;88(3):539\u201346.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"1251_CR4","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1111\/j.1468-3083.2012.04587.x","volume":"27","author":"T Ilves","year":"2013","unstructured":"Ilves T, Harvima IT. OX40 ligand and OX40 are increased in atopic dermatitis lesions but do not correlate with clinical severity. J Eur Acad Dermatol Venereol. 2013;27(2):e197\u2013205.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"1251_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/00019501-200002000-00013","volume":"11","author":"Y Oishi","year":"2000","unstructured":"Oishi Y, Wakatsuki T, Nishikado A, et al. Circulating adhesion molecules and severity of coronary atherosclerosis. Coron Artery Dis. 2000;11(1):77\u201381.","journal-title":"Coron Artery Dis"},{"issue":"7","key":"1251_CR6","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/S0735-1097(02)01728-X","volume":"39","author":"M Haim","year":"2002","unstructured":"Haim M, Tanne D, Boyko V, et al. Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. Data from the Bezafibrate infarction prevention (BIP) study. J Am Coll Cardiol. 2002;39(7):1133\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"1251_CR7","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1253\/circj.CJ-16-0924","volume":"80","author":"MF Linton","year":"2016","unstructured":"Linton MF, Babaev VR, Huang J, et al. Macrophage apoptosis and Efferocytosis in the pathogenesis of atherosclerosis. Circ J. 2016;80(11):2259\u201368.","journal-title":"Circ J"},{"issue":"03","key":"1251_CR8","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1160\/TH14-12-1014","volume":"114","author":"M Hoke","year":"2015","unstructured":"Hoke M, Winter MP, Wagner O, et al. The impact of selectins on mortality in stable carotid atherosclerosis. Thromb Haemost. 2015;114(03):632\u20138.","journal-title":"Thromb Haemost"},{"key":"1251_CR9","doi-asserted-by":"crossref","unstructured":"Nasiri-Ansari \u039d, Dimitriadis GK, Agrogiannis G, et al. Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice. Cardiovasc Diabetol. 2018;17:106.","DOI":"10.1186\/s12933-018-0749-1"},{"issue":"6","key":"1251_CR10","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.arcmed.2014.07.002","volume":"45","author":"ME Soto","year":"2014","unstructured":"Soto ME, Reyesvillatoro MA, M\u00e1rquez R, et al. Evaluation and analysis of plasma soluble adhesion molecules in patients with coronary ectasia and atherosclerotic coronary artery disease. Arch Med Res. 2014;45(6):478\u201383.","journal-title":"Arch Med Res"},{"issue":"3","key":"1251_CR11","first-page":"665","volume":"140","author":"RN Poston","year":"1992","unstructured":"Poston RN, Haskard DO, Coucher JR, et al. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol. 1992;140(3):665\u201373.","journal-title":"Am J Pathol"},{"issue":"3","key":"1251_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4331\/wjbc.v6.i3.209","volume":"6","author":"K Husain","year":"2015","unstructured":"Husain K, Hernandez W, Ansari RA, et al. Inflammation, oxidative stress and renin angiotensin system in atherosclerosis. World J Biol Chem. 2015;6(3):209\u201317.","journal-title":"World J Biol Chem"},{"key":"1251_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ijcard.2017.01.013","volume":"232","author":"V Marzolla","year":"2017","unstructured":"Marzolla V, Armani A, Mammi C, et al. Essential role of ICAM-1 in aldosterone-induced atherosclerosis. Int J Cardiol. 2017;232:233\u201342.","journal-title":"Int J Cardiol"},{"key":"1251_CR14","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.6061\/clinics\/2018\/e203","volume":"73","author":"JCD Santos","year":"2018","unstructured":"Santos JCD, Cruz MS, Bortolin RH, et al. Relationship between circulating VCAM-1, ICAM-1, E-selectin and MMP9 and the extent of coronary lesions. Clinics (Sao Paulo). 2018;73:e203.","journal-title":"Clinics (Sao Paulo)"},{"issue":"11","key":"1251_CR15","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1161\/ATVBAHA.107.149179","volume":"27","author":"E Galkina","year":"2007","unstructured":"Galkina E, Ley K. Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27(11):2292\u2013301.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"1251_CR16","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.4103\/0366-6999.233953","volume":"131","author":"CY Ma","year":"2018","unstructured":"Ma CY, Xu ZY, Wang SP, et al. Change of inflammatory factors in patients with acute coronary syndrome. Chin Med J. 2018;131(12):1444\u20139.","journal-title":"Chin Med J"},{"issue":"1","key":"1251_CR17","doi-asserted-by":"publisher","first-page":"31525","DOI":"10.3402\/fnr.v60.31525","volume":"60","author":"TA Rahman","year":"2016","unstructured":"Rahman TA, Hassim NF, Zulkafli N, et al. Atheroprotective effects of pure tocotrienol supplementation in the treatment of rabbits with experimentally induced early and established atherosclerosis. Food Nutr Res. 2016;60(1):31525.","journal-title":"Food Nutr Res"},{"issue":"9","key":"1251_CR18","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s11883-014-0435-z","volume":"16","author":"E Golia","year":"2014","unstructured":"Golia E, Limongelli G, Natale F, et al. Inflammation and cardiovascular disease: from pathogenesis to therapeutic target. Curr Atheroscler Rep. 2014;16(9):435.","journal-title":"Curr Atheroscler Rep"},{"issue":"22","key":"1251_CR19","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1111\/bph.13802","volume":"174","author":"AC Foks","year":"2017","unstructured":"Foks AC, Kuiper J. Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis. Br J Pharmacol. 2017;174(22):3940\u201355.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"1251_CR20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00109-008-0412-5","volume":"87","author":"PS Olofsson","year":"2009","unstructured":"Olofsson PS, S\u00f6derstr\u00f6m LA, Jern C, et al. Genetic variants of TNFSF4 and risk for carotid artery disease and stroke. J Mol Med (Berl). 2009;87(4):337\u201346.","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"1251_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1600-065X.2009.00766.x","volume":"229","author":"M Croft","year":"2010","unstructured":"Croft M, So T, Duan W, et al. The significance of OX40 and OX40L to T-cell biology and immune disease. Immunol Rev. 2010;229(1):173\u201391.","journal-title":"Immunol Rev"},{"issue":"1","key":"1251_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cca.2008.07.003","volume":"397","author":"DM Liu","year":"2008","unstructured":"Liu DM, Yan JC, Wang CP, et al. The clinical implications of increased OX40 ligand expression in patients with acute coronary syndrome. Clin Chim Acta. 2008;397(1):22\u20136.","journal-title":"Clin Chim Acta"},{"issue":"9\u201310","key":"1251_CR23","first-page":"449","volume":"56","author":"DQ Peng","year":"2010","unstructured":"Peng DQ, Huang S, Yuan SG, et al. Increased soluble OX40L is associated with carotid intima-media thickness. Clin Lab. 2010;56(9\u201310):449\u201357.","journal-title":"Clin Lab"},{"issue":"4","key":"1251_CR24","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1177\/147323001103900415","volume":"39","author":"JZ Shi","year":"2011","unstructured":"Shi JZ, Wang LY, Zhu Y, et al. OX40 ligand levels and high-sensitivity C-reactive protein levels in blood from local coronary plaque and the femoral artery in patients with acute coronary syndrome or stable angina. J Int Med Res. 2011;39(4):1275\u201383.","journal-title":"J Int Med Res"},{"issue":"4","key":"1251_CR25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/ng1524","volume":"37","author":"X Wang","year":"2005","unstructured":"Wang X, Ria M, Kelmenson PM, et al. Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Nat Genet. 2005;37(4):365\u201372.","journal-title":"Nat Genet"},{"issue":"1","key":"1251_CR26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1161\/01.ATV.0000251007.07648.81","volume":"27","author":"EJ van Wanrooij","year":"2007","unstructured":"van Wanrooij EJ, van Puijvelde GH, de Vos P, et al. Interruption of the Tnfrsf4\/Tnfsf4 (OX40\/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol. 2007;27(1):204\u201310.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"1251_CR27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s12016-015-8498-3","volume":"50","author":"GJ Webb","year":"2016","unstructured":"Webb GJ, Hirschfield GM, Lane PJ. OX40, OX40L and autoimmunity: a comprehensive review. Clin Rev Allergy Immunol. 2016;50(3):312\u201332.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1251_CR28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2147\/JIR.S170262","volume":"11","author":"Y Koh","year":"2018","unstructured":"Koh Y, Park J. Cell adhesion molecules and exercise. J Inflamm Res. 2018;11:297\u2013306.","journal-title":"J Inflamm Res"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-019-1251-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-019-1251-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-019-1251-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T06:13:04Z","timestamp":1665123184000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-019-1251-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,29]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1251"],"URL":"https:\/\/doi.org\/10.1186\/s12872-019-1251-8","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,29]]},"assertion":[{"value":"27 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was based on the \u201cAnatomy Rules\u201d promulgated by the Ministry of Health of the People\u2019s Republic of China and approved by the Ethics Committee of Guizhou Medical University(Lot No.: 2018 Renxu No. 01) .The measures described in this study conform to the requirements of the operation Committee of the ethics committee of Guizhou Medical University which accords with the requirements of China\u2019s Ministry of health, the State Food and Drug Administration and other relevant ministries and commissions of the state on the protection of human subjects in research ethics research, and the relevant international guidelines.We further declare that none of us in this researcher have any or potential conflicts of interest with the subjects and research projects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We declare that we have no financial or personal relationships with other people or organizations that could have influenced the writing of the manuscript entitled \u201cThe Role of OX40L and ICAM-1 in the Stability of Coronary Atherosclerotic Plaques and Their Relationship with Sudden Coronary Death\u201d.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"272"}}